Order Article Reprints

Baltussen JC, Welters MJP, Verdegaal EME, Kapiteijn E, Schrader AMR, Slingerland M, Liefers G-J, van der Burg SH, Portielje JEA, de Glas NA. Predictive Biomarkers for Outcomes of Immune Checkpoint Inhibitors (ICIs) in Melanoma: A Systematic Review. Cancers. 2021; 13(24):6366. https://doi.org/10.3390/cancers13246366

Baltussen, Joosje C., Marij J. P. Welters, Elizabeth M. E. Verdegaal, Ellen Kapiteijn, Anne M. R. Schrader, Marije Slingerland, Gerrit-Jan Liefers, Sjoerd H. van der Burg, Johanneke E. A. Portielje, and Nienke A. de Glas. 2021. "Predictive Biomarkers for Outcomes of Immune Checkpoint Inhibitors (ICIs) in Melanoma: A Systematic Review" Cancers 13, no. 24: 6366. https://doi.org/10.3390/cancers13246366

Baltussen, J. C., Welters, M. J. P., Verdegaal, E. M. E., Kapiteijn, E., Schrader, A. M. R., Slingerland, M., Liefers, G.-J., van der Burg, S. H., Portielje, J. E. A., & de Glas, N. A. (2021). Predictive Biomarkers for Outcomes of Immune Checkpoint Inhibitors (ICIs) in Melanoma: A Systematic Review. Cancers, 13(24), 6366. https://doi.org/10.3390/cancers13246366